Evidence map›Paper›PMID 32023805›Full record

ArticleMarine drugs2020

Impact of Prevalence Ratios of Chondroitin Sulfate (CS)- 4 and -6 Isomers Derived from Marine Sources in Cell Proliferation and Chondrogenic Differentiation Processes.

Estefanía López-Senra, Paula Casal-Beiroa, Miriam López-Álvarez, Julia Serra, Pío González, Jesus Valcarcel, José Antonio Vázquez, Elena F Burguera, Francisco J Blanco, Joana Magalhães

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Amentadione from the AlgaMarine drugs · 2020
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Estefanía López-SenraNew Materials Group, Department of Applied Physics, University of Vigo, IISGS, MTI, Campus Lagoas-Marcosende, 36310 Vigo, Spain.
Paula Casal-BeiroaUnidad de Medicina Regenerativa, Grupo de Investigación en Reumatología, Instituto de Investigación Biomédica de A Coruña (INIBIC), CHUAC. SERGAS. C/ As Xubias de Arriba 84, 15006 A Coruña, Spain.
Miriam López-ÁlvarezNew Materials Group, Department of Applied Physics, University of Vigo, IISGS, MTI, Campus Lagoas-Marcosende, 36310 Vigo, Spain.
Julia SerraNew Materials Group, Department of Applied Physics, University of Vigo, IISGS, MTI, Campus Lagoas-Marcosende, 36310 Vigo, Spain.
Pío GonzálezNew Materials Group, Department of Applied Physics, University of Vigo, IISGS, MTI, Campus Lagoas-Marcosende, 36310 Vigo, Spain.
Jesus ValcarcelGrupo de Reciclado y Valorización de Materiales Residuales (REVAL), Instituto de Investigacións Mariñas (IIM-CSIC), Eduardo Cabello 6, 36208 Vigo, Spain.
José Antonio VázquezGrupo de Reciclado y Valorización de Materiales Residuales (REVAL), Instituto de Investigacións Mariñas (IIM-CSIC), Eduardo Cabello 6, 36208 Vigo, Spain.
Elena F BurgueraUnidad de Medicina Regenerativa, Grupo de Investigación en Reumatología, Instituto de Investigación Biomédica de A Coruña (INIBIC), CHUAC. SERGAS. C/ As Xubias de Arriba 84, 15006 A Coruña, Spain.
Francisco J BlancoUnidad de Medicina Regenerativa, Grupo de Investigación en Reumatología, Instituto de Investigación Biomédica de A Coruña (INIBIC), CHUAC. SERGAS. C/ As Xubias de Arriba 84, 15006 A Coruña, Spain.
Joana MagalhãesUnidad de Medicina Regenerativa, Grupo de Investigación en Reumatología, Instituto de Investigación Biomédica de A Coruña (INIBIC), CHUAC. SERGAS. C/ As Xubias de Arriba 84, 15006 A Coruña, Spain.
Universidade da Coruña · ESUniversidade de Vigo · ESInstituto de Investigacións Mariñas · ES

Funding

Instituto de Salud Carlos III Biomedical Research Network Center (CIBER)INTERREG V-A POCTEP Program through European FEDER funds 0245_IBEROS_1_EXunta de Galicia AE CICA-INIBIC (AGRUP 2015/05)Xunta de Galicia Grupos de Potencial Crecimiento IN607B 2018/19Xunta de Galicia IN607A 2017/11
6 · The paper itself

Abstract

Osteoarthritis is the most prevalent rheumatic disease. During disease progression, differences have been described in the prevalence of chondroitin sulfate (CS) isomers. Marine derived-CS present a higher proportion of the 6S isomer, offering therapeutic potential. Accordingly, we evaluated the effect of exogenous supplementation of CS, derived from the small spotted catshark (

Indexed as

AgedAged, 80 and overAnimalsCattleCell DifferentiationCell LineCell ProliferationChondrocytesChondrogenesisChondroitin SulfatesFemaleHumansIsomerismMaleMesenchymal Stem CellsOsteoblastsChondroitin Sulfateschondrogenesischondroitin sulfatecircular economyfishery by-productsmarine compoundsosteoarthritis

Identifiers

PMID32023805
PMCPMC7074435
OpenAlexW3003263728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.